Aadi Bioscience Patent-Cliff Exposure & CMS Drug Spending Portfolio
Aadi Bioscience (Pacific Palisades, CA): 1 reconciled FDA prescription therapies, $1.5M 2024 CMS Part D & Medicaid spend, and 4 CA HCAI SB 17 wholesale price filings.
| Regulatory & Reimbursement Dimension | Verified Value |
|---|---|
| Headquarters / Cluster | Pacific Palisades, CA |
| Reconciled FDA Portfolio Therapies | 1 |
| 2025 to 2030 Patent-Cliff Revenue Exposure | 0.0% |
| Primary Portfolio LOE Date | 2040-01-01 |
| 2024 CMS Total Public Spend | $1.5M |
| 2024 Medicare Part D Spend | $0 |
| 2024 Medicaid Spend | $1.5M |
| California HCAI SB 17 Filings | 4 WAC filings (max 24.7% 2-yr change) |